Company profile
REGENERA
Let's make paralysis a thing of the past!
- Industry
- Biotechnology Research
- Employees
- 6
- Headquarters
- Vienna
- Founded
- 2021
- Office locations
- 2
REGENERA company summary
REGENERA is a company in the Biotechnology Research industry, headquartered in Vienna, founded in 2021. On LinkedIn the company has around 6 employees. The company lists 2 office locations. Its listed specialties include Regenerative Medicine, Tissue engineering, Neuroengineering, Stem Cells, Biomaterials.
What technology does REGENERA use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About REGENERA
Regenera is an Austrian-Swiss medtech start-up, aiming at translating into clinics its proprietary innovative combined approach for acute spinal cord injury repair. Spinal cord injuries, mostly of traumatic origin, are complex multi-factorial pathologies that currently impact ca. 250’000 new patients yearly worldwide, leaving them with permanent neurological impairments. Spinal cord injury has still unmet clinical needs: present tentative therapies indeed target at best only single components of this multi-factorial complex pathology. In this complex framework, Regenera proposes its proprietary innovative combined biomaterial and stem cells paradigm to counteract the cascade of events that follow after cord lesion, to be applied after standard anti-inflammatory therapy during post traumatic stabilization surgery: trophic support to tissue plasticity will be provided by locally grafting, outside lesioned parenchyma, autologous stem cells duly hosted into its proprietary innovative injectable resorbable hydrogel (SpinoSave®). Using the paracrine effect of the stem cells, the damaged tissue will be progressively led toward (self) regeneration to achieve cord functionality restoration.
Specialties
Where is REGENERA located?
REGENERA lists 2 office locations.
Compare companies similar to REGENERA
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
REGENERA regenera.ch | Biotechnology Research | 6 | 2021 | Vienna |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about REGENERA
What does REGENERA do?
Regenera is an Austrian-Swiss medtech start-up, aiming at translating into clinics its proprietary innovative combined approach for acute spinal cord injury repair. Spinal cord injuries, mostly of traumatic origin, are complex multi-factorial pathologies that currently impact ca. 250’000 new patients yearly worldwide, leaving them with permanent neurological impairments. Spinal cord injury has still unmet clinical needs: present tentative therapies indeed target at best only single components of this multi-factorial complex pathology. In this complex framework, Regenera proposes its proprietary innovative combined biomaterial and stem cells paradigm to counteract the cascade of events that follow after cord lesion, to be applied after standard anti-inflammatory therapy during post traumatic stabilization surgery: trophic support to tissue plasticity will be provided by locally grafting, outside lesioned parenchyma, autologous stem cells duly hosted into its proprietary innovative injectable resorbable hydrogel (SpinoSave®). Using the paracrine effect of the stem cells, the damaged tissue will be progressively led toward (self) regeneration to achieve cord functionality restoration.
How many employees does REGENERA have?
REGENERA has around 6 employees on LinkedIn.
Where is REGENERA headquartered?
REGENERA is headquartered in Vienna.
Where does REGENERA have offices?
REGENERA lists 2 office locations, including Vienna, 1030, AT; Lugano, 6900, CH.
When was REGENERA founded?
REGENERA was founded in 2021.
Build a lead list from companies like REGENERA
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.